BioSpace News Archive

Drug Development

Evotec Receives Milestone Payment for First Patient Dosed in Phase I Study of Bayer Kidney Disease Programme

Evotec SE announced that it is to receive a € 2 m milestone payment from Bayer AG, which is triggered by the first patient dosed in the clinical Phase I study of a kidney disease programme stemming from the Evotec-Bayer multi-target research collaboration in kidney diseases.

June 29, 2023
·
5 min read
Devyser Launches Two New Genetic Testing Solutions for Hereditary Cancer

Devyser is thrilled to announce the launch of two new products, Devyser LynchFAP and Devyser BRCA PALB2.

June 29, 2023
·
3 min read
Biotech Bay

Mainz Biomed Secures up to $50M in New Funding

Mainz Biomed NV announced that it has entered into a $50 million Pre-Paid Advance Agreement with Yorkville Advisors Global, LP, a global investment management firm.

June 29, 2023
·
5 min read
Drug Development

Positive results in uPAR-PET/MR Phase II study in brain cancer: Curasight

Curasight A/S announces positive results from the investigator-initiated phase II study using uPAR-PET in primary brain cancer.

June 29, 2023
·
3 min read
Policy

ZAP Surgical Receives National Medical Products Administration (NMPA) Approval in China

ZAP Surgical Systems, Inc., a leading innovator in the field of surgical robotics, announced that the company received National Medical Products Administration approval in China for its ZAP-X® Gyroscopic Radiosurgery® platform.

June 29, 2023
·
2 min read
Genetown

Jacobio Pharma Presents Clinical Results of Glecirasib in Colorectal Cancer

Jacobio Pharma announced clinical results of its novel KRAS G12C inhibitor glecirasib monotherapy and in combination therapy with cetuximab to treat KRAS G12C mutant advanced CRC in Second JCA- AACR Precision Medicine International Conference.

June 29, 2023
·
2 min read
Immuno-oncology company Biosyngen opens new cell therapy GMP facility in Singapore

Biosyngen, an immune-oncology company with technology targeting the unmet medical needs in solid tumour and lymphoma treatment, announced the official opening of its latest Good Manufacturing Practice facility in Singapore.

June 29, 2023
·
6 min read
Business

Ribbon Biolabs Appoints Roopom Banerjee as Executive Chairman

Ribbon Biolabs, the DNA synthesis company, announced the appointment of Roopom Banerjee as Executive Chairman of its Board of Directors.

June 29, 2023
·
3 min read
Job Trends

BioMed X Institute Starts Its First Research Project With Sanofi on Artificial Intelligence for Drug Development

BioMed X, a German independent research institute, announces the start of its first research project in collaboration with Sanofi: “Next Generation Virtual Patient Engine for Clinical Translation of Drug Candidates”.

June 29, 2023
·
2 min read
Policy

Italfarmaco Group Completes FDA Submission of New Drug Application for Givinostat in Duchenne Muscular Dystrophy and Receives Priority Review

Italfarmaco Group announced that the U.S. Food and Drug Administration has completed its filing review and accepted the company’s New Drug Application for Givinostat.

June 29, 2023
·
4 min read